Literature DB >> 7129438

Muscle provocation test. A sensitive method for discrimination between carriers and noncarriers of Duchenne muscular dystrophy.

F H Herrmann, A Spiegler, G Wiedemann.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1982        PMID： 7129438     DOI： 10.1007/bf00274196

Source DB:  PubMed          Journal:  Hum Genet        ISSN： 0340-6717            Impact factor:   4.132


× No keyword cloud information.
  5 in total

1.  [Standard method for the determination of creatine kinase activity].

Authors: 
Journal:  J Clin Chem Clin Biochem       Date:  1977-04

2.  International Committee for Standardization in Hematology (ICSH), International Federation of Clinical Chemistry (IFCC), World Association of (Anatomic and Clinical) Pathology Societies (WAPS): Recommendation for use of SI in clinical laboratory measurements.

Authors: 
Journal:  Z Klin Chem Klin Biochem       Date:  1973-02

3.  The use of serum creatine phosphokinase in genetic counseling for Duchenne muscular dystrophy. II. Review of methods of assay and factors which may be relevant in the interpretation of serum creatine phosphokinase activity.

Authors:  A N Gale; E A Murphy
Journal:  J Chronic Dis       Date:  1979

4.  Studies of the carrier state in the Duchenne type of muscular dystrophy. I. Effect of exercise on serum creatine kinase activity.

Authors:  P Hudgson; D Gardner-Medwin; R J Pennington; J N Walton
Journal:  J Neurol Neurosurg Psychiatry       Date:  1967-10       Impact factor: 10.154

5.  Serum creatine kinase studies in the detection of carriers of Duchenne dystrophy.

Authors:  R C Hughes; D C Park; M E Parsons; M D O'Brien
Journal:  J Neurol Neurosurg Psychiatry       Date:  1971-10       Impact factor: 10.154
  5 in total
  4 in total

Review 1.  Mechanisms of resistance to pathogenesis in muscular dystrophies.

Authors:  J P Infante; V A Huszagh
Journal:  Mol Cell Biochem       Date:  1999-05       Impact factor: 3.396

2.  Myoglobin is a sensitive marker of increased muscle membrane vulnerability.

Authors:  M F Driessen-Kletter; G J Amelink; P R Bär; J van Gijn
Journal:  J Neurol       Date:  1990-07       Impact factor: 4.849

Review 3.  Duchenne muscular dystrophy: pathogenetic aspects and genetic prevention.

Authors:  H Moser
Journal:  Hum Genet       Date:  1984       Impact factor: 4.132

4.  A comparison of the effects of simvastatin and pravastatin monotherapy on muscle histology and permeability in hypercholesterolaemic patients.

Authors:  J Contermans; J W Smit; P R Bär; D W Erkelens
Journal:  Br J Clin Pharmacol       Date:  1995-02       Impact factor: 4.335
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.